Switch to
Place Order
Dr. Lal PathLabs Ltd
LALPATHLAB
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹15,871 cr, stock is ranked 257
Moderate RiskStock is 2.36x as volatile as Nifty
1,960.452.38% (+45.55)
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹15,871 cr, stock is ranked 257
Moderate RiskStock is 2.36x as volatile as Nifty
Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 48.59 | 10.85 | 0.60% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 33.63 | 4.12 | 0.94% |
Forecast & RatingsDetailed Forecast
25%
Analysts have suggested that investors can buy this stock
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Apollo Hospitals Enterprise Ltd
PE Ratio
57.64
1Y Return
3.57%
Buy Reco %
100.00
Max Healthcare Institute Ltd
PE Ratio
70.75
1Y Return
25.85%
Buy Reco %
100.00
Fortis Healthcare Ltd
PE Ratio
37.83
1Y Return
5.46%
Buy Reco %
100.00
Narayana Hrudayalaya Ltd
PE Ratio
42.85
1Y Return
10.64%
Buy Reco %
87.50
Global Health Ltd
PE Ratio
60.13
1Y Return
0.00%
Buy Reco %
100.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Revenue
Profit
All values in ₹ Thousand cr.
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Dr. Lal Pathlabs Q3 Results Review - Weak Volume Outlook: Yes Securities
5 days ago•Bloomberg Quint
Dr Lal PathLabs Q3 Results: Net profit drops 8% to Rs 54 crore
5 days ago•Economic Times
Lal PathLabs slips after Q3 PAT falls nearly 8% YoY; EBITDA at Rs 122 crore
5 days ago•Business Standard
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant